Share

Networks

Clinical Studies (6)

  • MIViral : Study aims to learn about the influence of pre-existing mucosal immunity, i.e. antibodies and immune cells that are present at the nasal mucosa before infection, on the infectious viral load after infection with SARS-CoV-2, influenza virus and RSV
  • SwissPrEPared : Study aims to determine the incidence of gonorrhoea, chlamydia, and syphilis in the ongoing SwissPrEPared cohort over a 3-year period and to evaluate the association between STI diagnosis and behavioural factors such as condom use, number of partners, and substance use in a sexual context
  • Aguilaniu : Study aims to conduct a large descriptive analysis of cardiopulmonary exercise testing to improve the understanding of persistent symptoms and in particular the diversity of physiological response presentations in post acut SARS-CoV-2 infection patients
  • Exquis : Study aims to assess the frequency and adequacy of the use of antiviral drugs (nirmatrelvir/ritonavir or remdesivir) in elderly patients hospitalised with mild-to-moderate COVID-19
  • UNITY : Study aims to evaluate the clinical efficacy and safety of tecovirimat treatment in patients with mpox
  • FunkeChambour : Study aims to establish a meticulously characterised study on pulmonary long-term sequela of patients living in Switzerland

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Adolescents (12-17 years)
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Monkeypox virus
  • Respiratory syncytial virus
  • Influenza virus
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Post COVID-19 condition
  • Acute COVID-19
  • Mpox
  • Respiratory syncytial virus infection
  • Influenza
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Nirmatrelvir/Ritonavir
  • Tecovirimat
  • PrEP-bSTI

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to